0001077183-21-000111.txt : 20210421 0001077183-21-000111.hdr.sgml : 20210421 20210421181959 ACCESSION NUMBER: 0001077183-21-000111 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210419 FILED AS OF DATE: 20210421 DATE AS OF CHANGE: 20210421 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mallon Mark CENTRAL INDEX KEY: 0001763533 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35756 FILM NUMBER: 21842692 MAIL ADDRESS: STREET 1: C/O IRONWOOD PHARMACEUTICALS, INC. STREET 2: 100 SUMMER STREET, SUITE 2300 CITY: BOSTON STATE: MA ZIP: 02110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEOGENOMICS INC CENTRAL INDEX KEY: 0001077183 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734] IRS NUMBER: 742897368 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12701 COMMONWEALTH DRIVE STREET 2: SUITE 9 CITY: FORT MYERS STATE: FL ZIP: 33913 BUSINESS PHONE: 9419231949 MAIL ADDRESS: STREET 1: 12701 COMMONWEALTH DRIVE STREET 2: SUITE 9 CITY: FORT MYERS STATE: FL ZIP: 33913 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN COMMUNICATIONS ENTERPRISES INC DATE OF NAME CHANGE: 19990120 4 1 wf-form4_161904358115470.xml FORM 4 X0306 4 2021-04-19 0 0001077183 NEOGENOMICS INC NEO 0001763533 Mallon Mark 12701 COMMONWEALTH DRIVE SUITE 9 FORT MYERS FL 33913 1 1 0 0 Chief Executive Officer Common Stock 2021-04-19 4 A 0 55736 0 A 55736 D Stock Option (Right to Buy) 49.34 2021-04-19 4 A 0 151016 0 A 2028-04-19 Common Stock 151016.0 151016 D On April 19, 2021, Mr. Mallon was granted 151,016 stock options. These options vest ratably over the first four anniversary dates of the grant date. /s/ Mark W. Mallon 2021-04-21